TY - JOUR
T1 - ANGIOGRAPHIC SUBTYPES OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN TAIWAN A Prospective Multicenter Study
AU - Yeung, Ling
AU - Kuo, Chien-Neng
AU - Chao, An-Ning
AU - Chen, Kuan-Jen
AU - Wu, Wei-Chi
AU - Lai, Chien-Hsiung
AU - Wang, Nan-Kai
AU - Hwang, Yih-Shiou
AU - Chen, Ching-Lung
AU - Lai, Chi-Chun
PY - 2018
Y1 - 2018
N2 - Purpose: To determine the incidence and clinical characteristics of angiographic subtypes of polypoidal choroidal vasculopathy (PCV).
Methods: It is a prospective, multicenter, cross-sectional study. Patients with newly diagnosed exudative macular degeneration are classified into PCV, age-related macular degeneration (AMD), and retinal angiomatous proliferation. Polypoidal choroidal vasculopathy is further classified into two subtypes depending on the presence (Type 1: polypoidal choroidal neovascularization) or absence (Type 2: typical PCV) of feeder vessels on indocyanine green angiography.
Results: We enrolled 169 patients: 76 (45%) with PCV, 75 (44.4%) with AMD, and 14 (8.3%) with retinal angiomatous proliferation. Of the patients with PCV, 20 (26%) were classified as Type 1 PCV and 56 (74%) were classified as Type 2 PCV. The Type 1 PCV had a similar mean age compared to the AMD group (73.1 +/- 9.6 vs. 75.6 +/- 8.8 years, P = 0.281) and the Type 2 PCV (68.8 +/- 9.6 years) was younger than the AMD group (P, 0.001). Type 1 PCV presented with worse visual acuity compared with the AMD. Both PCV subtypes had a higher incidence of hemorrhagic complications (85% and 75% respectively).
Conclusion: Type 2 PCV is more common than Type 1 PCV in Taiwan. Our results support the hypothesis that polypoidal choroidal neovascularization and typical PCV may be distinct entities.
AB - Purpose: To determine the incidence and clinical characteristics of angiographic subtypes of polypoidal choroidal vasculopathy (PCV).
Methods: It is a prospective, multicenter, cross-sectional study. Patients with newly diagnosed exudative macular degeneration are classified into PCV, age-related macular degeneration (AMD), and retinal angiomatous proliferation. Polypoidal choroidal vasculopathy is further classified into two subtypes depending on the presence (Type 1: polypoidal choroidal neovascularization) or absence (Type 2: typical PCV) of feeder vessels on indocyanine green angiography.
Results: We enrolled 169 patients: 76 (45%) with PCV, 75 (44.4%) with AMD, and 14 (8.3%) with retinal angiomatous proliferation. Of the patients with PCV, 20 (26%) were classified as Type 1 PCV and 56 (74%) were classified as Type 2 PCV. The Type 1 PCV had a similar mean age compared to the AMD group (73.1 +/- 9.6 vs. 75.6 +/- 8.8 years, P = 0.281) and the Type 2 PCV (68.8 +/- 9.6 years) was younger than the AMD group (P, 0.001). Type 1 PCV presented with worse visual acuity compared with the AMD. Both PCV subtypes had a higher incidence of hemorrhagic complications (85% and 75% respectively).
Conclusion: Type 2 PCV is more common than Type 1 PCV in Taiwan. Our results support the hypothesis that polypoidal choroidal neovascularization and typical PCV may be distinct entities.
KW - CHINESE PATIENTS
KW - CLASSIFICATION
KW - CLINICAL CHARACTERISTICS
KW - DISEASE
KW - JAPANESE
KW - MACULAR DEGENERATION
KW - PHOTODYNAMIC THERAPY
KW - age-related macular degeneration
KW - choroidal neovascularization
KW - polypoidal choroidal neovascularization
KW - polypoidal choroidal vasculopathy
KW - retinal angiomatous proliferation
M3 - Journal Article
SN - 0275-004X
VL - 38
SP - 263
EP - 271
JO - RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
JF - RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
IS - 2
ER -